The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Opioid Use Disorder Market Research Report 2025

Global Opioid Use Disorder Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1707789

No of Pages : 75

Ask Your Query
Synopsis
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.

The global Opioid Use Disorder market was valued at US$ 1747.7 million in 2023 and is anticipated to reach US$ 2660 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Opioid Use Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Use Disorder.

Report Scope

The Opioid Use Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioid Use Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Opioid Use Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Indivior

Alkermes

Titan Pharmaceuticals

Hikma Pharmaceuticals

Teva Pharmaceuticals

MediciNova

Orexo

Camurus

Omeros

Segment by Type

Buprenorphine

Methadone

Naltrexone

Segment by Application

Moderate Pain Treatment

Severe Pain Treatment

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Opioid Use Disorder companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Opioid Use Disorder Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Buprenorphine

1.2.3 Methadone

1.2.4 Naltrexone

1.3 Market by Application

1.3.1 Global Opioid Use Disorder Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Moderate Pain Treatment

1.3.3 Severe Pain Treatment

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Opioid Use Disorder Market Perspective (2019-2030)

2.2 Opioid Use Disorder Growth Trends by Region

2.2.1 Global Opioid Use Disorder Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Opioid Use Disorder Historic Market Size by Region (2019-2024)

2.2.3 Opioid Use Disorder Forecasted Market Size by Region (2025-2030)

2.3 Opioid Use Disorder Market Dynamics

2.3.1 Opioid Use Disorder Industry Trends

2.3.2 Opioid Use Disorder Market Drivers

2.3.3 Opioid Use Disorder Market Challenges

2.3.4 Opioid Use Disorder Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Opioid Use Disorder Players by Revenue

3.1.1 Global Top Opioid Use Disorder Players by Revenue (2019-2024)

3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2019-2024)

3.2 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Opioid Use Disorder Revenue

3.4 Global Opioid Use Disorder Market Concentration Ratio

3.4.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2023

3.5 Opioid Use Disorder Key Players Head office and Area Served

3.6 Key Players Opioid Use Disorder Product Solution and Service

3.7 Date of Enter into Opioid Use Disorder Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid Use Disorder Breakdown Data by Type

4.1 Global Opioid Use Disorder Historic Market Size by Type (2019-2024)

4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2025-2030)

5 Opioid Use Disorder Breakdown Data by Application

5.1 Global Opioid Use Disorder Historic Market Size by Application (2019-2024)

5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Opioid Use Disorder Market Size (2019-2030)

6.2 North America Opioid Use Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Opioid Use Disorder Market Size by Country (2019-2024)

6.4 North America Opioid Use Disorder Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Opioid Use Disorder Market Size (2019-2030)

7.2 Europe Opioid Use Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Opioid Use Disorder Market Size by Country (2019-2024)

7.4 Europe Opioid Use Disorder Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Opioid Use Disorder Market Size (2019-2030)

8.2 Asia-Pacific Opioid Use Disorder Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Opioid Use Disorder Market Size by Region (2019-2024)

8.4 Asia-Pacific Opioid Use Disorder Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Opioid Use Disorder Market Size (2019-2030)

9.2 Latin America Opioid Use Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Opioid Use Disorder Market Size by Country (2019-2024)

9.4 Latin America Opioid Use Disorder Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Opioid Use Disorder Market Size (2019-2030)

10.2 Middle East & Africa Opioid Use Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Opioid Use Disorder Market Size by Country (2019-2024)

10.4 Middle East & Africa Opioid Use Disorder Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Indivior

11.1.1 Indivior Company Detail

11.1.2 Indivior Business Overview

11.1.3 Indivior Opioid Use Disorder Introduction

11.1.4 Indivior Revenue in Opioid Use Disorder Business (2019-2024)

11.1.5 Indivior Recent Development

11.2 Alkermes

11.2.1 Alkermes Company Detail

11.2.2 Alkermes Business Overview

11.2.3 Alkermes Opioid Use Disorder Introduction

11.2.4 Alkermes Revenue in Opioid Use Disorder Business (2019-2024)

11.2.5 Alkermes Recent Development

11.3 Titan Pharmaceuticals

11.3.1 Titan Pharmaceuticals Company Detail

11.3.2 Titan Pharmaceuticals Business Overview

11.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction

11.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024)

11.3.5 Titan Pharmaceuticals Recent Development

11.4 Hikma Pharmaceuticals

11.4.1 Hikma Pharmaceuticals Company Detail

11.4.2 Hikma Pharmaceuticals Business Overview

11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction

11.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024)

11.4.5 Hikma Pharmaceuticals Recent Development

11.5 Teva Pharmaceuticals

11.5.1 Teva Pharmaceuticals Company Detail

11.5.2 Teva Pharmaceuticals Business Overview

11.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction

11.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024)

11.5.5 Teva Pharmaceuticals Recent Development

11.6 MediciNova

11.6.1 MediciNova Company Detail

11.6.2 MediciNova Business Overview

11.6.3 MediciNova Opioid Use Disorder Introduction

11.6.4 MediciNova Revenue in Opioid Use Disorder Business (2019-2024)

11.6.5 MediciNova Recent Development

11.7 Orexo

11.7.1 Orexo Company Detail

11.7.2 Orexo Business Overview

11.7.3 Orexo Opioid Use Disorder Introduction

11.7.4 Orexo Revenue in Opioid Use Disorder Business (2019-2024)

11.7.5 Orexo Recent Development

11.8 Camurus

11.8.1 Camurus Company Detail

11.8.2 Camurus Business Overview

11.8.3 Camurus Opioid Use Disorder Introduction

11.8.4 Camurus Revenue in Opioid Use Disorder Business (2019-2024)

11.8.5 Camurus Recent Development

11.9 Omeros

11.9.1 Omeros Company Detail

11.9.2 Omeros Business Overview

11.9.3 Omeros Opioid Use Disorder Introduction

11.9.4 Omeros Revenue in Opioid Use Disorder Business (2019-2024)

11.9.5 Omeros Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Buprenorphine

Table 3. Key Players of Methadone

Table 4. Key Players of Naltrexone

Table 5. Global Opioid Use Disorder Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Opioid Use Disorder Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Opioid Use Disorder Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Opioid Use Disorder Market Share by Region (2019-2024)

Table 9. Global Opioid Use Disorder Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Opioid Use Disorder Market Share by Region (2025-2030)

Table 11. Opioid Use Disorder Market Trends

Table 12. Opioid Use Disorder Market Drivers

Table 13. Opioid Use Disorder Market Challenges

Table 14. Opioid Use Disorder Market Restraints

Table 15. Global Opioid Use Disorder Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Opioid Use Disorder Market Share by Players (2019-2024)

Table 17. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2023)

Table 18. Ranking of Global Top Opioid Use Disorder Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Opioid Use Disorder Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Opioid Use Disorder Product Solution and Service

Table 22. Date of Enter into Opioid Use Disorder Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Opioid Use Disorder Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Opioid Use Disorder Revenue Market Share by Type (2019-2024)

Table 26. Global Opioid Use Disorder Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Opioid Use Disorder Revenue Market Share by Type (2025-2030)

Table 28. Global Opioid Use Disorder Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Opioid Use Disorder Revenue Market Share by Application (2019-2024)

Table 30. Global Opioid Use Disorder Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Opioid Use Disorder Revenue Market Share by Application (2025-2030)

Table 32. North America Opioid Use Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Opioid Use Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Opioid Use Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Opioid Use Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Opioid Use Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Opioid Use Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Opioid Use Disorder Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Opioid Use Disorder Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Opioid Use Disorder Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Opioid Use Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Opioid Use Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Opioid Use Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Opioid Use Disorder Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Opioid Use Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Opioid Use Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 47. Indivior Company Detail

Table 48. Indivior Business Overview

Table 49. Indivior Opioid Use Disorder Product

Table 50. Indivior Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 51. Indivior Recent Development

Table 52. Alkermes Company Detail

Table 53. Alkermes Business Overview

Table 54. Alkermes Opioid Use Disorder Product

Table 55. Alkermes Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 56. Alkermes Recent Development

Table 57. Titan Pharmaceuticals Company Detail

Table 58. Titan Pharmaceuticals Business Overview

Table 59. Titan Pharmaceuticals Opioid Use Disorder Product

Table 60. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 61. Titan Pharmaceuticals Recent Development

Table 62. Hikma Pharmaceuticals Company Detail

Table 63. Hikma Pharmaceuticals Business Overview

Table 64. Hikma Pharmaceuticals Opioid Use Disorder Product

Table 65. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 66. Hikma Pharmaceuticals Recent Development

Table 67. Teva Pharmaceuticals Company Detail

Table 68. Teva Pharmaceuticals Business Overview

Table 69. Teva Pharmaceuticals Opioid Use Disorder Product

Table 70. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 71. Teva Pharmaceuticals Recent Development

Table 72. MediciNova Company Detail

Table 73. MediciNova Business Overview

Table 74. MediciNova Opioid Use Disorder Product

Table 75. MediciNova Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 76. MediciNova Recent Development

Table 77. Orexo Company Detail

Table 78. Orexo Business Overview

Table 79. Orexo Opioid Use Disorder Product

Table 80. Orexo Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 81. Orexo Recent Development

Table 82. Camurus Company Detail

Table 83. Camurus Business Overview

Table 84. Camurus Opioid Use Disorder Product

Table 85. Camurus Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 86. Camurus Recent Development

Table 87. Omeros Company Detail

Table 88. Omeros Business Overview

Table 89. Omeros Opioid Use Disorder Product

Table 90. Omeros Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 91. Omeros Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Opioid Use Disorder Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Opioid Use Disorder Market Share by Type: 2023 VS 2030

Figure 3. Buprenorphine Features

Figure 4. Methadone Features

Figure 5. Naltrexone Features

Figure 6. Global Opioid Use Disorder Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Opioid Use Disorder Market Share by Application: 2023 VS 2030

Figure 8. Moderate Pain Treatment Case Studies

Figure 9. Severe Pain Treatment Case Studies

Figure 10. Opioid Use Disorder Report Years Considered

Figure 11. Global Opioid Use Disorder Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Opioid Use Disorder Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Opioid Use Disorder Market Share by Region: 2023 VS 2030

Figure 14. Global Opioid Use Disorder Market Share by Players in 2023

Figure 15. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2023

Figure 17. North America Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Opioid Use Disorder Market Share by Country (2019-2030)

Figure 19. United States Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Opioid Use Disorder Market Share by Country (2019-2030)

Figure 23. Germany Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Opioid Use Disorder Market Share by Region (2019-2030)

Figure 31. China Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Opioid Use Disorder Market Share by Country (2019-2030)

Figure 39. Mexico Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Opioid Use Disorder Market Share by Country (2019-2030)

Figure 43. Turkey Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 46. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 47. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 48. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 50. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 51. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 52. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 53. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock